ASSET PURCHASE AGREEMENT BY AND BETWEEN BLOOD AND PLASMA RESEARCH, INC. AND KAMADA PLASMA, LLC Dated as of January 31, 2021Asset Purchase Agreement • February 24th, 2021 • Kamada LTD • Pharmaceutical preparations • Texas
THIS ASSET INTEREST PURCHASE AGREEMENT (this “Agreement”) is made and entered into as of January 31, 2021, by and between Blood and Plasma Research, Inc., a Texas corporation (“Seller”), and Kamada Plasma, LLC, a Delaware limited liability company (“Buyer”).
DISTRIBUTION AGREEMENTDistribution Agreement • February 24th, 2021 • Kamada LTD • Pharmaceutical preparations • London
Kamada Ltd., a company duly incorporated and registered under the laws of the State of Israel, with principal offices at 2 Holzman Street, Weizmann Science Park, Rehovot 7670402, Israel (the “Supplier”)
CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT IS BOTH (i) NOT MATERIAL AND (ii) WOULD LIKELY CAUSE COMPETITIVE HARM TO THE COMPANY IF PUBLICLY DISCLOSED. [*****] indicates the redacted confidential portions of this...Co-Development, Manufacturing, Supply and Distribution Agreement • February 24th, 2021 • Kamada LTD • Pharmaceutical preparations
Recitals This Binding Term Sheet (“Term Sheet”) summarizes the main terms and conditions under which Kamada Ltd., of 2 Holzman St. Science Park, P.O. Box 4801, Rehovot, 7670402, Israel (“KAMADA”) and Kedrion S.p.A, of Castelvecchio Pascoli, Località Ai Conti, 55051 Barga (LU), Italy (“KEDRION”) will enter into a long-term agreement for the co-development, manufacturing, supply and distribution of the Product (as defined below) (Each of KAMADA and KEDRION is referred to hereunder as a “Party” and together the “Parties”). By signing this Term Sheet, the Parties agree to be legally bound by the provisions set forth below, and each Party shall be legally bound to proceed to negotiate and execute a definitive agreement or agreements for the co-development, manufacturing, supply of Source Plasma (as defined below) and Product (as defined below), distribution and quality as may be required, and any other related agreements (collectively, the “Definitive Agreements” and individually, a “Defini
